News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Flynn James E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
SC 13G
| Flynn James E reports a 5.9% stake in Cabaletta Bio, Inc. |
| 05/18/2023 |
SC 13G
| Flynn James E reports a 5.5% stake in Amedisys, Inc. |
| 04/06/2023 |
SC 13G
| Flynn James E reports a 5.5% stake in Owens & Minor, Inc. |
| 03/22/2023 |
SC 13G
| Flynn James E reports a 6.1% stake in Deciphera Pharmaceuticals, Inc. |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2023 |
SC 13G
| Flynn James E reports a 7.3% stake in GeneDX Holdings Corp. |
| 12/23/2022 |
SC 13G
| Flynn James E reports a 5.9% stake in Terns Pharmaceuticals, Inc. |
| 11/18/2022 |
SC 13G
| Flynn James E reports a 10% stake in Rain Therapeutics, Inc. |
| 11/17/2022 |
SC 13G
| Flynn James E reports a 6.5% stake in Brookdale Senior Living Inc. |
| 11/16/2022 |
SC 13G
| Flynn James E reports a 5.1% stake in Abeona Therapeutics, Inc. |
| 11/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/14/2022 |
SC 13G
| Flynn James E reports a 5.7% stake in Enhabit, Inc. |
| 10/04/2022 |
SC 13G
| Flynn James E reports a 5.6% stake in * IVERIC bio, Inc. |
| 09/30/2022 |
SC 13G
| Flynn James E reports a 5.5% stake in Merus N.V. |
| 09/23/2022 |
SC 13G
| Flynn James E reports a 5.8% stake in Phathom Pharmaceuticals, Inc. |
| 08/16/2022 |
SC 13G
| Flynn James E reports a 5.8% stake in Vigil Neuroscience, Inc. |
| 08/15/2022 |
SC 13G
| Flynn James E reports a 5.2% stake in AnaptysBio, Inc. |
| 06/17/2022 |
SC 13G
| Flynn James E reports a 9.6% stake in Cogent Biosciences, Inc. |
| 06/06/2022 |
SC 13G
| Flynn James E reports a 5.4% stake in Evolus, Inc. |
| 05/19/2022 |
SC 13G
| Flynn James E reports a 6.7% stake in ImmunoGen, Inc. |
| 05/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2022 |
SC 13G
| Flynn James E reports a 45.1% stake in Nuvalent, Inc. |
| 01/24/2022 |
SC 13G
| Flynn James E reports a 5.3% stake in Silk Road Medical, Inc. |
| 12/07/2021 |
SC 13G
| Flynn James E reports a 8.2% stake in Esperion Therapeutics, Inc. |
| 12/03/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/10/2021 |
SC 13G
| Flynn James E reports a 7.2% stake in Deciphera Pharmaceuticals, Inc. |
| 09/28/2021 |
SC 13G
| Flynn James E reports a 6.6% stake in Vincerx Pharma, Inc. |
| 08/16/2021 |
SC 13G
| Flynn James E reports a 5.4% stake in Aerie Pharmaceuticals, Inc. |
| 08/05/2021 |
SC 13G
| Flynn James E reports a 6.9% stake in Apria, Inc. |
| 08/02/2021 |
SC 13G
| Flynn James E reports a 5.8% stake in Sema4 Holding Corp. |
| 07/16/2021 |
SC 13G
| Flynn James E reports a 5.4% stake in Pulmonx Corporation |
|
|
|